Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Radiological Investigation III: Pulmonary Angiogram and PET Scan01:13

Radiological Investigation III: Pulmonary Angiogram and PET Scan

732
Radiological investigations are paramount in the diagnosis and management of various pulmonary diseases. Two essential investigations are the Pulmonary Angiogram and the Positron Emission Tomography (PET) Scan.
Pulmonary Angiogram
A Pulmonary Angiogram is an invasive procedure involving injecting a contrast medium through a catheter threaded into the pulmonary artery or the right side of the heart to visualize the pulmonary vasculature. Computed Tomography (CT) scans have mainly replaced this...
732
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

764
Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
764

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: How safe is teaching radical cystectomy?

World journal of urology·2026
Same author

Long-term citrate treatment in high-risk kidney stone formers is not associated with metabolic adverse effects.

Clinical kidney journal·2026
Same author

En-bloc HoLEP training and learning curve challenges: a multi-generational survey study.

World journal of urology·2026
Same author

Crystal structures of an azo-benzene-bridged aza-18-crown-6 cryptand and a sodium complex thereof.

Acta crystallographica. Section E, Crystallographic communications·2026
Same author

How safe is teaching radical cystectomy? : Results from the prospective Swiss society of urology database.

World journal of urology·2026
Same author

Interdisciplinary Swiss consensus recommendations for follow-up after radical cystectomy and trimodal treatment for muscle-invasive bladder cancer.

Bladder cancer (Amsterdam, Netherlands)·2026
Same journal

Contemporary Practices in the Assessment and Management of Climacturia: Results from an International Survey.

European urology open science·2026
Same journal

Optimization of Thulium Fiber Laser Lithotripsy Efficacy Based on Multidimensional Parameter Combination Strategies.

European urology open science·2026
Same journal

Incorporating Lower Urinary Tract Symptoms to Predict the Risk of Positive Prostate Magnetic Resonance Imaging.

European urology open science·2026
Same journal

Early Efficacy and Exploratory Biomarker Data of Bel-sar in Patients with Intermediate-risk and High-risk Non-muscle-invasive Bladder Cancer.

European urology open science·2026
Same journal

Long-term Outcomes in Men with Stable PSA During 5-α Reductase Inhibitor Therapy After Negative Prostate Biopsy: Population-based Study.

European urology open science·2026
Same journal

Corrigendum to "Long-term real-world survival outcomes with dual immune checkpoint blockade in synchronous metastatic renal cell carcinoma: implications for the design of prospective cytoreductive nephrectomy trials" [Eur. Urol. Open Sci. 83 (2026) 133-141].

European urology open science·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K

Predicting Urinary Function Outcomes Following Low-dose-rate Brachytherapy for Prostate Cancer.

Gianni Rüedi1, Manolis Pratsinis1, Hans-Peter Schmid1

  • 1Department of Urology, St. Gallen Cantonal Hospital, St. Gallen, Switzerland.

European Urology Open Science
|December 19, 2024
PubMed
Summary
This summary is machine-generated.

Predicting urinary function after prostate cancer brachytherapy is possible using pre-treatment symptoms and prostate size. This tool aids in personalized treatment planning for better patient outcomes.

Keywords:
Low-dose-rate brachytherapyLower urinary tract symptomsOutcome predictionProstate cancerUrinary function

More Related Videos

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.0K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

Related Experiment Videos

Last Updated: May 6, 2026

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
07:25

A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer

Published on: March 6, 2018

13.0K
Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser
07:17

Photoselective Vaporesection of the Prostate via an End-firing Lithium Triborate Crystal Laser

Published on: May 9, 2018

8.0K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

20.3K

Area of Science:

  • Urology
  • Radiation Oncology
  • Medical Informatics

Background:

  • Localized prostate cancer treatment often involves low-dose-rate brachytherapy (LDR-BT).
  • Predicting post-treatment urinary function is crucial for patient quality of life.
  • Existing prediction tools may not fully utilize readily available clinical parameters.

Purpose of the Study:

  • To develop a predictive tool for poor urinary function following LDR-BT for prostate cancer.
  • To identify key pre-interventional clinical parameters associated with urinary dysfunction.
  • To aid in individualized treatment planning for prostate cancer patients undergoing LDR-BT.

Main Methods:

  • Analysis of a prospective Swiss LDR-BT cohort (n=607) with a minimum 3-year follow-up.
  • Assessment of pre-interventional variables including International Prostate Symptom Score (IPSS) and prostate volume (PV).
  • Logistic regression and receiver operating characteristic (ROC) curve analysis to identify predictors of poor urinary function (defined as IPSS-Quality of Life >3 or TURP).

Main Results:

  • Poor urinary function was observed in 5.0% of patients.
  • Pre-interventional IPSS (aOR 1.18) and PV (aOR 1.04) were significant predictors of poor urinary function.
  • Study limitations include potential selection bias and lack of external validation.

Conclusions:

  • Pre-treatment IPSS and PV are significant predictors of post-LDR-BT urinary function.
  • A risk calculator based on these parameters can assist in personalized treatment planning.
  • Further validation is needed before routine clinical application.